adplus-dvertising
Connect with us

Business

Feds sign deal with Novavax to secure up to 76M doses of vaccine candidate – CTV News

Published

 on


OTTAWA —
The federal government has reached agreements with Novavax and Johnson & Johnson to secure millions of doses of COVID-19 vaccine candidates.

The deals hinge on Health Canada approval but if trials proceed as planned, deliveries in Canada would begin at the start of 2021. The government has also inked deals with pharmaceutical firms Pfizer and Moderna for access to millions of doses of their unique candidates.

“Taken together, our vaccine agreements with Pfizer, Moderna, Novavax, and Johnson & Johnson, will give Canada at least 88 million doses, with options to obtain tens of millions more,” said Trudeau during a press conference on Monday.

“Once a vaccine is proven to work, we’ll also need to be able to produce and distribute it here at home.”

To date, Novavax will supply 76 million doses of NVX-CoV2373, Moderna will supply 56 million of mRNA-1273, Johnson & Johnson will supply 38 million of Ad26.COV2.S, and Pfizer will supply 20 million BNT162.

Trudeau also announced the government would be spending $126 million to expand the bio-manufacturing facility at the National Research Council in Montreal, with a projected deadline of mid-2021.

“This funding will increase this facility’s ability to manufacture vaccines and will strengthen the NRC’s partnerships with vaccine developers.”

Infectious disease specialist Dr. Isaac Bogoch says the candidate still has a variety of regulatory hurdles to overcome before it gets the green light but this step indicates Canada is well positioned in the global race to find a COVID-19 vaccine.

“It’s wonderful to see that the federal government is looking at vaccine candidates, looking at which ones could be successful. We appreciate that some of these might not be successful and we’re sort of hedging our bets and we’ll have access to vaccines when they become available,” he told CTV News Channel on Monday.

This follows news last week that Chinese customs halted the shipment of CanSino Biologics’ vaccine candidate to Canada, denying the opportunity to commence human trials here.

“Due to the delay in the shipment of the vaccine doses to Canada it is evident this specific opportunity is over and the NRC is focusing its team and facilities on other partners and COVID-19 priorities,” the National Research Council said in a statement on Thursday.

Trudeau responded to the move on Monday, saying he had hoped the long-standing partnership between the Canadian government and CanSino would have proved fruitful amid COVID-19 after successfully partnering with the company to combat the Ebola virus.

“Unfortunately China didn’t grant export permits for the vaccine to Canada so we’re continuing to focus on the many other paths that are very promising,” he said.

While multiple trials testing various vaccine candidates are progressing around the world, there is currently no accepted cure or vaccine for the novel coronavirus.

In a follow-up press conference on Monday, Health Minister Patty Hajdu said COVID-19 immunization will not be mandatory but Canadians can be assured that Health Canada’s regulatory process will yield a safe vaccine.

“We want to be very clear, Health Canada will not authorize a vaccine unless scientific evidence demonstrates that it is safe and effective,” she said. “Even in this accelerated environment, health-care officials are working around the clock to ensure Canada is well prepared when a safe vaccine becomes available.”

She praised Canadians for having a high degree of vaccine literacy when compared internationally, but warned of misinformation online.

“It’s so important that Canadians use credible sources when they’re looking for information about this vaccine and any other,” she said. “Including your family doctor, local public health units, or by visiting Health Canada’s website.”

VACCINE STRATEGY

Asked about which countries will get access to what and when, Minister of Procurement Anita Anand said the government’s strategy to diversify suppliers will place Canada at the “front of the line.”

“At this stage, no one knows which vaccine is going to be successful. Therefore, we need to have many options on the table for Canadians and I will assure you that we aren’t on a frolic of our own in this decision-making.”

While Canada won’t have hands on the production of these vaccine candidates, Anand said investments like that in the NRC will help bolster the country’s abilities in the longer term.

“We need to make sure just as we did with PPE that there is a Canadian answer here.”

Let’s block ads! (Why?)

728x90x4

Source link

Business

Roots sees room for expansion in activewear, reports $5.2M Q2 loss and sales drop

Published

 on

 

TORONTO – Roots Corp. may have built its brand on all things comfy and cosy, but its CEO says activewear is now “really becoming a core part” of the brand.

The category, which at Roots spans leggings, tracksuits, sports bras and bike shorts, has seen such sustained double-digit growth that Meghan Roach plans to make it a key part of the business’ future.

“It’s an area … you will see us continue to expand upon,” she told analysts on a Friday call.

The Toronto-based retailer’s push into activewear has taken shape over many years and included several turns as the official designer and supplier of Team Canada’s Olympic uniform.

But consumers have had plenty of choice when it comes to workout gear and other apparel suited to their sporting needs. On top of the slew of athletic brands like Nike and Adidas, shoppers have also gravitated toward Lululemon Athletica Inc., Alo and Vuori, ramping up competition in the activewear category.

Roach feels Roots’ toehold in the category stems from the fit, feel and following its merchandise has cultivated.

“Our product really resonates with (shoppers) because you can wear it through multiple different use cases and occasions,” she said.

“We’ve been seeing customers come back again and again for some of these core products in our activewear collection.”

Her remarks came the same day as Roots revealed it lost $5.2 million in its latest quarter compared with a loss of $5.3 million in the same quarter last year.

The company said the second-quarter loss amounted to 13 cents per diluted share for the quarter ended Aug. 3, the same as a year earlier.

In presenting the results, Roach reminded analysts that the first half of the year is usually “seasonally small,” representing just 30 per cent of the company’s annual sales.

Sales for the second quarter totalled $47.7 million, down from $49.4 million in the same quarter last year.

The move lower came as direct-to-consumer sales amounted to $36.4 million, down from $37.1 million a year earlier, as comparable sales edged down 0.2 per cent.

The numbers reflect the fact that Roots continued to grapple with inventory challenges in the company’s Cooper fleece line that first cropped up in its previous quarter.

Roots recently began to use artificial intelligence to assist with daily inventory replenishments and said more tools helping with allocation will go live in the next quarter.

Beyond that time period, the company intends to keep exploring AI and renovate more of its stores.

It will also re-evaluate its design ranks.

Roots announced Friday that chief product officer Karuna Scheinfeld has stepped down.

Rather than fill the role, the company plans to hire senior level design talent with international experience in the outdoor and activewear sectors who will take on tasks previously done by the chief product officer.

This report by The Canadian Press was first published Sept. 13, 2024.

Companies in this story: (TSX:ROOT)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Talks on today over HandyDART strike affecting vulnerable people in Metro Vancouver

Published

 on

 

VANCOUVER – Mediated talks between the union representing HandyDART workers in Metro Vancouver and its employer, Transdev, are set to resume today as a strike that has stopped most services drags into a second week.

No timeline has been set for the length of the negotiations, but Joe McCann, president of the Amalgamated Transit Union Local 1724, says they are willing to stay there as long as it takes, even if talks drag on all night.

About 600 employees of the door-to-door transit service for people unable to navigate the conventional transit system have been on strike since last Tuesday, pausing service for all but essential medical trips.

Hundreds of drivers rallied outside TransLink’s head office earlier this week, calling for the transportation provider to intervene in the dispute with Transdev, which was contracted to oversee HandyDART service.

Transdev said earlier this week that it will provide a reply to the union’s latest proposal on Thursday.

A statement from the company said it “strongly believes” that their employees deserve fair wages, and that a fair contract “must balance the needs of their employees, clients and taxpayers.”

This report by The Canadian Press was first published Sept. 12, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending